Correction to: LINC01013 Is a Determinant of Fibroblast Activation and Encodes a Novel Fibroblast-Activating Micropeptide.
Saved in:
| Title: | Correction to: LINC01013 Is a Determinant of Fibroblast Activation and Encodes a Novel Fibroblast-Activating Micropeptide. |
|---|---|
| Authors: | Quaife NM; National Heart and Lung Institute, Imperial College London, London, UK.; MRC London Institute of Medical Sciences, London, UK., Chothani S; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore, Singapore, 169857, Singapore., Schulz JF; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany., Lindberg EL; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Vanezis K; National Heart and Lung Institute, Imperial College London, London, UK.; MRC London Institute of Medical Sciences, London, UK., Adami E; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore, Singapore, 169857, Singapore.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., O'Fee K; MRC London Institute of Medical Sciences, London, UK., Greiner J; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Litviňuková M; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., van Heesch S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Whiffin N; National Heart and Lung Institute, Imperial College London, London, UK.; Cardiovascular Research Centre, Royal Brompton and Harefield Hospitals, Guy's and St Thomas NHS Foundation Trust, London, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Hubner N; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany., Schafer S; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore, Singapore, 169857, Singapore., Rackham O; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore, Singapore, 169857, Singapore., Cook SA; MRC London Institute of Medical Sciences, London, UK.; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore, Singapore, 169857, Singapore.; National Heart Centre Singapore, Singapore, Singapore., Barton PJR; National Heart and Lung Institute, Imperial College London, London, UK. p.barton@imperial.ac.uk.; MRC London Institute of Medical Sciences, London, UK. p.barton@imperial.ac.uk.; Cardiovascular Research Centre, Royal Brompton and Harefield Hospitals, Guy's and St Thomas NHS Foundation Trust, London, UK. p.barton@imperial.ac.uk. |
| Source: | Journal of cardiovascular translational research [J Cardiovasc Transl Res] 2023 Feb; Vol. 16 (1), pp. 86. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101468585 Publication Model: Print Cited Medium: Internet ISSN: 1937-5395 (Electronic) Linking ISSN: 19375387 NLM ISO Abbreviation: J Cardiovasc Transl Res Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1937-5395 |
|---|---|
| DOI: | 10.1007/s12265-022-10291-4 |
